Jasper Therapeutics's total assets for Q3 2023 were $110.41M, a decrease of -11.08% from the previous quarter. JSPR total liabilities were $16.27M for the fiscal quarter, a 16.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.